BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 8376700)

  • 1. Atrial natriuretic peptide in heart failure.
    Brandt RR; Wright RS; Redfield MM; Burnett JC
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):86A-92A. PubMed ID: 8376700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The atrial peptide system in cardiac disease.
    Burnett JC
    Am J Hypertens; 1988 Oct; 1(4 Pt 2):410S-420S. PubMed ID: 2973331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atrial natriuretic peptide in cardiac insufficiency].
    Riegger AJ
    Arzneimittelforschung; 1988 Mar; 38(3A):479-83. PubMed ID: 2969247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of congestive heart failure: role of atrial natriuretic factor and therapeutic implications.
    Perrella MA; Margulies KB; Burnett JC
    Can J Physiol Pharmacol; 1991 Oct; 69(10):1576-81. PubMed ID: 1838025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormones in heart failure--regulation and counterregulation.
    Riegger AJ
    Eur Heart J; 1991 Aug; 12 Suppl D():190-2. PubMed ID: 1833197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cardiac preload by atrial natriuretic peptide in congestive cardiac failure.
    Johnston CI; Hodsman GP; Harrison RW; Mendelsohn FA; Tsunoda K
    Am J Med; 1988 Mar; 84(3A):105-11. PubMed ID: 2851266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between atrial natriuretic peptide, renin system and vasopressin in heart failure.
    Riegger AJ
    Eur Heart J; 1990 Apr; 11 Suppl B():79-83. PubMed ID: 2142083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic factor: physiologic actions and implications in congestive heart failure.
    Edwards BS; Zimmerman RS; Burnett JC
    Cardiovasc Drugs Ther; 1987; 1(1):89-100. PubMed ID: 2978996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
    Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
    Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of vasoactive hormones in congestive cardiac failure.
    Johnston CI; Arnolda LF; Tsunoda K; Phillips PA; Hodsman GP
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1706-11. PubMed ID: 2961425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal role of the endogenous natriuretic peptide system in acute congestive heart failure.
    Stevens TL; Rasmussen TE; Wei CM; Kinoshita M; Matsuda Y; Burnett JC
    J Card Fail; 1996 Jun; 2(2):119-25. PubMed ID: 8798113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurohumoral regulation in heart failure].
    Riegger GA; Muders F; Luchner A
    Z Kardiol; 1996; 85 Suppl 6():205-10. PubMed ID: 9064967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction.
    Redfield MM; Aarhus LL; Wright RS; Burnett JC
    Circulation; 1993 Jun; 87(6):2016-22. PubMed ID: 8504516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognized molecular mechanisms of heart failure: approaches to treatment.
    Ceconi C; Cargnoni A; Curello S; Ferrari R
    Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II79-91. PubMed ID: 9835784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in neurohumoral systems during the development of congestive heart failure: impact on cardiovascular and renal function.
    Elsner D
    Eur Heart J; 1995 Dec; 16 Suppl N():52-8. PubMed ID: 8682062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists.
    Johnston CI; Hodsman PG; Kohzuki M; Casley DJ; Fabris B; Phillips PA
    Am J Med; 1989 Dec; 87(6B):24S-28S. PubMed ID: 2532457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
    Martin FL; Stevens TL; Cataliotti A; Schirger JA; Borgeson DD; Redfield MM; Luchner A; Burnett JC
    Kidney Int; 2005 May; 67(5):1723-30. PubMed ID: 15840018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endogenous atrial natriuretic factor in acute congestive heart failure.
    Lee ME; Miller WL; Edwards BS; Burnett JC
    J Clin Invest; 1989 Dec; 84(6):1962-6. PubMed ID: 2531762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of neuroendocrine mechanisms in the pathogenesis of heart failure.
    Riegger AJ
    Basic Res Cardiol; 1991; 86 Suppl 3():125-31. PubMed ID: 1838244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.